NYCLA Amicus Curiae Host Daniel K. Wiig sits down with former Assistant Director Strategic Planning, White House Office of National Drug Control Policy (1997-2001 William Clinton Administration), Robert Hausman. In October 2021, the FTC sued Xlear, Inc., a Utah-based company, for violating the COVID-19 Consumer Protection Act, alleging that it falsely pitched its saline nasal sprays as an effective way to prevent and treat COVID-19. DOJ filed the complaint on the FTC’s behalf. United States of America v. Xlear, Inc. This case concerns COVID-19, the FTC, and free speech. Listen to this interesting conversation discussing the nuances of the case, and its possible ramifications on free speech. Has science become a victim of politics?  Guest Information Robert Housman, Partner, Book Hill Partners; General Counsel, Xlear; Consultant 360 Law Group; 360 Business Law America